Market Cap 198.15M
Revenue (ttm) 0.00
Net Income (ttm) -19.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 123,300
Avg Vol 164,322
Day's Range N/A - N/A
Shares Out 14.68M
Stochastic %K 45%
Beta 1.40
Analysts Strong Sell
Price Target $57.00

Company Profile

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States. Its lead product candidate is GP2, a HER2/neu transmembrane peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients. The company also develops FLAMINGO-01, which is in Phase IIb and 3 Phase I clinical trial designed to evaluate the safety and efficacy of GLSI-100 in HER2...

Industry: Biotechnology
Sector: Healthcare
Phone: 832-819-3232
Address:
Building 14, 3992 Bluebonnet Dr., Stafford, United States
Rolltide2020
Rolltide2020 Aug. 4 at 2:07 PM
$GLSI It's hard waiting for the good news you know is coming so the price gets to where you know it should be.
0 · Reply
jm4
jm4 Aug. 4 at 12:47 PM
$GLSI hot pharma summer
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 4 at 12:30 AM
$GLSI blocked on stupidity
0 · Reply
Biotechgod66
Biotechgod66 Aug. 3 at 9:28 PM
$GLSI i like ceo and i like the treatment but we buy stocks and chart looks as bad as it gets. obvious bear flag after big break of the rectangle which i noted last time i posted on Glsi. price target is $8, same as last time i posted. market not interested in ceo’s small purchases. he already owns a significant chunk of co. and stock is at $14. ph 3 for these type of cancer bios are very long and very tough. i wish co. all the best but $8 is definitely coming.
0 · Reply
RiderInTheSky
RiderInTheSky Aug. 3 at 3:47 PM
$GLSI thinking we may get more news 🗞️ this wk. Possibly tomorrow
1 · Reply
yft212
yft212 Aug. 3 at 2:51 PM
0 · Reply
analysiser
analysiser Aug. 3 at 12:54 AM
0 · Reply
Waterwing
Waterwing Aug. 1 at 8:25 PM
$GLSI Broad national and international participation in the Greenwich LifeSciences, Inc. Phase III trial can be viewed with credibility and feasibility... Reasons it can be encouraging: Regulatory and site acceptance: Multiple clinical sites and countries participating generally means the therapy and trial design passed review by investigators and regulatory bodies in those regions. Physician interest: Researchers and clinicians usually do not commit significant resources to a large Phase III trial unless they believe the scientific rationale is reasonable. Patient recruitment strength. Potential commercial relevance.
0 · Reply
telomerase
telomerase Jul. 31 at 10:08 PM
$GLSI @Bob_Whitley > All we need is the CEO/CFO to buy another 700 shares and we are off to the races/ Oh right, because then he'd have 5,612,102 shares instead of 5,611,402. That would make all the difference. 🙄 You keep changing your profile name, but you still insist on announcing that you "have an MBA from an Ivy League school. I also drive a 2024 Mercedes and trade stocks from a 2,000 square foot condo in Miami, waterfront." Do you think that 2024 Mercedes protect you from crime or tsunamis? They certainly aren't protecting you from the consequences of your predictions... you spent a lot of time predicting that SLS would crash when it was in the 2s. You don't have much of a record, and living in a condo in a crime -riddenhurricane zone doesn't show good judgement either. And I'll bet the "Ivy League" school is in New Hampshire and was featured in the documentary "Animal House" with John Belushi. Try talking about the Flamingo open label data.
2 · Reply
Bob_Whitley
Bob_Whitley Jul. 31 at 7:50 PM
$GLSI All we need is the CEO/CFO to buy another 700 shares and we are off to the races/
0 · Reply
Latest News on GLSI
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

Jul 20, 2026, 6:00 AM EDT - 15 days ago

Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01


Greenwich LifeSciences Quarterly report: Q1 2026

Jun 4, 2026, 8:00 AM EDT - 2 months ago

Greenwich LifeSciences Quarterly report: Q1 2026


Greenwich LifeSciences presents FLAMINGO-01 data at ASCO

2026-06-01T14:32:25.000Z - 2 months ago

Greenwich LifeSciences presents FLAMINGO-01 data at ASCO


Greenwich LifeSciences Annual report: Q4 2025

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Greenwich LifeSciences Annual report: Q4 2025


Greenwich LifeSciences provides update on 10-K filing

2026-06-01T10:21:46.000Z - 2 months ago

Greenwich LifeSciences provides update on 10-K filing


Greenwich LifeSciences says Form 10-K ‘still being audited’

2026-04-30T10:11:17.000Z - 3 months ago

Greenwich LifeSciences says Form 10-K ‘still being audited’


Greenwich LifeSciences Provides Update on Financing Strategy

Apr 14, 2026, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences Provides Update on Financing Strategy


Greenwich LifeSciences adds City of Hope to FLAMINGO-01 trial

2026-03-19T10:12:27.000Z - 4 months ago

Greenwich LifeSciences adds City of Hope to FLAMINGO-01 trial


Greenwich LifeSciences Provides Update on Upcoming AACR Meeting

Mar 18, 2026, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting


Greenwich LifeSciences Transcript: Noble Conference

Dec 3, 2025, 7:00 AM EST - 8 months ago

Greenwich LifeSciences Transcript: Noble Conference


Greenwich LifeSciences Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 9 months ago

Greenwich LifeSciences Quarterly report: Q3 2025


Greenwich LifeSciences Proxy statement: Proxy filing

Nov 3, 2025, 7:00 AM EST - 9 months ago

Greenwich LifeSciences Proxy statement: Proxy filing


Greenwich LifeSciences Proxy statement: Proxy filing

Nov 3, 2025, 7:00 AM EST - 9 months ago

Greenwich LifeSciences Proxy statement: Proxy filing


Greenwich LifeSciences Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Greenwich LifeSciences Quarterly report: Q2 2025


Greenwich LifeSciences Slides: Corporate presentation

Jun 15, 2025, 7:00 AM EDT - 1 year ago

Greenwich LifeSciences Slides: Corporate presentation


Greenwich LifeSciences Quarterly report: Q1 2025

May 20, 2025, 8:00 AM EDT - 1 year ago

Greenwich LifeSciences Quarterly report: Q1 2025


Greenwich LifeSciences Annual report: Q4 2024

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Greenwich LifeSciences Annual report: Q4 2024


Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01


Greenwich LifeSciences Partners with GIM in Italy

Nov 26, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Partners with GIM in Italy


Greenwich LifeSciences Provides Update on Corporate Events

Nov 18, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Corporate Events


Greenwich LifeSciences Quarterly report: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Greenwich LifeSciences Quarterly report: Q3 2024


Greenwich LifeSciences Proxy statement: Proxy filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Greenwich LifeSciences Proxy statement: Proxy filing


Greenwich LifeSciences Proxy statement: Proxy filing

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Greenwich LifeSciences Proxy statement: Proxy filing


Greenwich LifeSciences Quarterly report: Q2 2024

Aug 14, 2024, 8:00 AM EDT - 2 years ago

Greenwich LifeSciences Quarterly report: Q2 2024


Greenwich LifeSciences Set to Join Russell 2000 Index Again

Jun 26, 2024, 7:33 AM EDT - 2 years ago

Greenwich LifeSciences Set to Join Russell 2000 Index Again


Greenwich LifeSciences Announces $2.5 Million Private Placement

Jun 14, 2024, 6:00 AM EDT - 2 years ago

Greenwich LifeSciences Announces $2.5 Million Private Placement


Rolltide2020
Rolltide2020 Aug. 4 at 2:07 PM
$GLSI It's hard waiting for the good news you know is coming so the price gets to where you know it should be.
0 · Reply
jm4
jm4 Aug. 4 at 12:47 PM
$GLSI hot pharma summer
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 4 at 12:30 AM
$GLSI blocked on stupidity
0 · Reply
Biotechgod66
Biotechgod66 Aug. 3 at 9:28 PM
$GLSI i like ceo and i like the treatment but we buy stocks and chart looks as bad as it gets. obvious bear flag after big break of the rectangle which i noted last time i posted on Glsi. price target is $8, same as last time i posted. market not interested in ceo’s small purchases. he already owns a significant chunk of co. and stock is at $14. ph 3 for these type of cancer bios are very long and very tough. i wish co. all the best but $8 is definitely coming.
0 · Reply
RiderInTheSky
RiderInTheSky Aug. 3 at 3:47 PM
$GLSI thinking we may get more news 🗞️ this wk. Possibly tomorrow
1 · Reply
yft212
yft212 Aug. 3 at 2:51 PM
0 · Reply
analysiser
analysiser Aug. 3 at 12:54 AM
0 · Reply
Waterwing
Waterwing Aug. 1 at 8:25 PM
$GLSI Broad national and international participation in the Greenwich LifeSciences, Inc. Phase III trial can be viewed with credibility and feasibility... Reasons it can be encouraging: Regulatory and site acceptance: Multiple clinical sites and countries participating generally means the therapy and trial design passed review by investigators and regulatory bodies in those regions. Physician interest: Researchers and clinicians usually do not commit significant resources to a large Phase III trial unless they believe the scientific rationale is reasonable. Patient recruitment strength. Potential commercial relevance.
0 · Reply
telomerase
telomerase Jul. 31 at 10:08 PM
$GLSI @Bob_Whitley > All we need is the CEO/CFO to buy another 700 shares and we are off to the races/ Oh right, because then he'd have 5,612,102 shares instead of 5,611,402. That would make all the difference. 🙄 You keep changing your profile name, but you still insist on announcing that you "have an MBA from an Ivy League school. I also drive a 2024 Mercedes and trade stocks from a 2,000 square foot condo in Miami, waterfront." Do you think that 2024 Mercedes protect you from crime or tsunamis? They certainly aren't protecting you from the consequences of your predictions... you spent a lot of time predicting that SLS would crash when it was in the 2s. You don't have much of a record, and living in a condo in a crime -riddenhurricane zone doesn't show good judgement either. And I'll bet the "Ivy League" school is in New Hampshire and was featured in the documentary "Animal House" with John Belushi. Try talking about the Flamingo open label data.
2 · Reply
Bob_Whitley
Bob_Whitley Jul. 31 at 7:50 PM
$GLSI All we need is the CEO/CFO to buy another 700 shares and we are off to the races/
0 · Reply
crypto_biotech
crypto_biotech Jul. 31 at 2:45 PM
$GLSI $13.77 He is already green & up. Some people are good at trades / Investing and reading tea leaves. In all seriousness- make some call to these cancer centers or visit some of the leading EMA INSTITUTES that are participating in the trial. I think you will be amazed at the high expectations they have based on their research. I don’t know of ANY cancer HER2+ ongoing trial anywhere that has the interest of as many big name Oncologists as a whole as Flamingo or GP2. Not many shares lest to short. I have to hand it to those shorting a Cancer stock- especially this one. As more and more women see cancer rates go up (Europe has a much higher HER2+ occurrence) I would think - if you believe in Karma- that tempting Karma with cancer is like trying to put a fire out worth premium gasoline. Good luck to us.
1 · Reply
ATXAMPEREStrategies
ATXAMPEREStrategies Jul. 31 at 1:37 PM
$GLSI $200M market cap is dump. This has 85% chance of success in which it will serve 10B market…….completely manipulated stock……should be trading $1B based on where it is in ph111…..
1 · Reply
ATXAMPEREStrategies
ATXAMPEREStrategies Jul. 31 at 1:33 PM
$GLSI every long I know, including some of my family members have put their shares in cash account. I actually dont believe fintel is anywhere close to accurate at the moment. Pull your shares back. The shorts worked hard to break this down…..we’ll be back to $30’s in no time…..
1 · Reply
Rolltide2020
Rolltide2020 Jul. 31 at 11:58 AM
$GLSI Only 15,000 shares to borrow. Thinking it was 150,000 yesterday.
1 · Reply
Stock_profit_03
Stock_profit_03 Jul. 31 at 4:08 AM
$GLSI https://youtu.be/WBGgFPcxXOg?is=5aAcV6y2OWb0Z3RH
0 · Reply
doc123266
doc123266 Jul. 30 at 6:30 PM
$GLSI I think the “A”(acquired) is as important
0 · Reply
Spammified
Spammified Jul. 30 at 4:51 PM
$GLSI had a limit buy set for ages at 12.6. Filled today. Don't tell me i actually for once on my life called the actual bottom?! 🙃
3 · Reply
Chgojoe
Chgojoe Jul. 30 at 4:43 PM
$GLSI Ya! A nice office. Look at the holders the the stock Theranos. The had a 116,000-square-foot corporate headquarters at 1701 Page Mill Road in Palo Alto, California, costing an estimated $1.73 million per month in rent, with the overall building valued at roughly $26.X million. Remember Elizabeth Holmes. I like the Industrial Park.
1 · Reply
CapSampler
CapSampler Jul. 30 at 4:10 PM
$GLSI that D letter on the fillings just tells everything.
2 · Reply
TheinvestmetABCD
TheinvestmetABCD Jul. 30 at 3:13 PM
$GLSI Snehal buying more increases the probability of a lockup extension to 90% plus and also that the open label arms is still extremely strong. If they release again great open label data, I am expecting more and more funds buying GLSI especially with the new protocol change increasing chances of approval significantly
0 · Reply
crypto_biotech
crypto_biotech Jul. 30 at 3:07 PM
$GLSI Fair, but what about the statement on 10 Institutions closing in the past 30 days? Or Phase 2 by MD Anderson? Or Phase 3 by Baylor? Or EMA endorsement via trials through some of the best cancer centers ? Or FDA Fast Track? I also poked around asking Oncology “experts” what they thought and even went as far as paying to find out about the new trial design. While binary in nature- our chances of interim success is much higher than Vegas roulette. Primary endpoint at end of trial seems better to me as well. Listen I like slots as much as any gambler- but these guys are looking for a p-value that removes any result due to chance. I’ve never see both American & EMA on board for a HER2+ Cancer Trial like this & neither has any Oncology doctor I’ve talked with. Good luck to every mom, daughter, grandma, aunt, etc & their families and Godspeed to this company’s success!
2 · Reply
mshah1615
mshah1615 Jul. 30 at 1:53 PM
0 · Reply